Evaluation of the efficacy of a peptide-derived absorbable haemostatic agent in the prevention of post-operative bleeding in artificial ulcers caused by colon and gastric submucosal dissection: a multi-centric prospective observational study.
Not Applicable
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Those with a history of hypersensitivity to peptide or protein preparations (2) Patients who are judged to be inappropriate to participate in this study by the principal investigator or research coordinator. (3) Patients who have been off antiplatelet agents or anticoagulants for more than 1 week during the perioperative period of ESD
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method